The first year of hair loss treatment: what the product information actually says

Twelve months of treatment produces a change smaller than the difference between two bathroom mirror photos. That is the whole problem with judging it by eye.
Combining hair loss treatments: what the licensed evidence actually covers

The pairing marketed everywhere as the gold standard is described by the UK product information in four words: no data are available.
Prostate symptoms and sex: what the treatments actually do

Two classes of prostate medicine, two completely different sexual effects, and a striking number of men who were never told about either.
Male fertility and sperm health: what the numbers mean and what changes them

A semen analysis is not a pass or a fail, the reference values changed and most of the internet hasn’t noticed, and nothing you do today shows up for three months.
Hair loss in your 20s: why it hits harder and why timing matters

The evidence that early hair loss hurts more is better than the evidence for most things sold to fix it. That is worth taking seriously in both directions.
Topical finasteride: what is actually available in the UK, and what gets absorbed

Marketed as the version without systemic effects. The phase III data show serum DHT falling by about a third, which is not nothing, and the pharmacovigilance data agree.
Dutasteride for hair loss: the licensing position, the evidence and the half-life problem

More potent, better hair counts in short trials, and a half-life measured in weeks rather than hours. That last fact is the one that ought to shape the decision.
Finasteride side effects: the trial numbers, the UK warnings and what changed in 2026

Two pictures of the same medicine: a percentage point or so of excess risk in the trials, and a body of persistent-symptom reports serious enough that three regulators have acted. Both are real.
Minoxidil for hair loss: how to use it properly and what results look like

It works while you use it and stops working when you don’t. Most disappointment with minoxidil is a dosing problem, not a drug problem.
Male pattern baldness: why it happens and what changes the course of it

It isn’t hair falling out so much as hair getting smaller each cycle. That distinction is why timing matters so much.